MAPK3 and glioma: Similar to LOXL2 knockdown, PD98059 or Erk1/2-specific siRNA inhibited the effects of LOXL2 on the regulation of Atg7 expression, which further affected the process of EMT and sensitivity to TMZ by inhibiting glioma cell autophagy.